SecBot SecBot
Home › SEC Filings › Current Report (8-K)

Current Report (8-K)

10,000+ reports analyzed by SecBot AI · browse by date or by stock
TickerTypeSentimentImpactSummaryDate
NRXP8-Kneutral2/10NRx Pharmaceuticals filed an 8-K to announce the 2026 Annual Meeting of Stockholders, scheduled for December 17, 2026, wOct 16, 2026
XTIA8-Kbearish7/10XTI Aerospace disclosed that its subsidiary, XTI Drones Holdings, defaulted on two promissory notes totaling approximateOct 16, 2026
NB8-Kneutral4/10NioCorp reported preliminary Q1 FY2027 (Sep 2026) net income of $3.7M ($0.03/share basic), swinging from a net loss of $Oct 16, 2026
ADIL8-Kbearish5/10Adial Pharmaceuticals further adjourned its 2026 Annual Meeting for the fourth time, from October 15 to October 26, 2026Oct 16, 2026
SBMT8-Kneutral3/10Silver Bow Mining amended CEO Travis Naugle's performance warrants, replacing an unachievable PEA milestone with two alrOct 16, 2026
MEDS8-Kmixed6/10DataMeds AI entered into an IP license agreement with REBOOT Health AI, issuing 666,667 shares valued at $2,000,000 for Oct 16, 2026
FMHS8-Kneutral3/10Farmhouse, Inc. announced the resignation of CFO Lanny R. Lang and the appointment of Kevin Asher as the new CFO, effectOct 16, 2026
MOBX8-Kbullish6/10Mobix Labs filed an 8-K furnishing the transcript of an October 8, 2026 investor call. The call provided a positive updaOct 16, 2026
ARI8-Kbearish8/10Apollo Commercial Real Estate Finance, Inc. (ARI) filed an 8-K announcing its voluntary delisting from the NYSE, with thOct 16, 2026
BLDR8-K/Aneutral2/10Builders FirstSource filed an amended 8-K to disclose the compensation package for Mike Hiller, who was previously annouOct 16, 2026
IAM8-Kneutral2/10Iambic Therapeutics filed an 8-K on October 16, 2026, reporting the adoption of amended and restated certificate of incoOct 16, 2026
BLIN8-Kbearish7/10Bridgeline Digital received a Nasdaq deficiency notice on October 14, 2026, for failing to maintain a minimum $1.00 bid Oct 16, 2026
NB8-Kneutral4/10NioCorp's subsidiary Elk Creek Resources Corp. entered into a comprehensive 15-year offtake agreement with Traxys North Oct 16, 2026
ROLR8-Kbearish7/10High Roller Technologies (ROLR) filed an 8-K announcing that its unaudited financial statements for Q1 and Q2 2026 can nOct 16, 2026
CGC8-Kbearish7/10Canopy Growth received a Nasdaq delisting notice on October 14, 2026, because its common shares traded below $1.00 for 3Oct 16, 2026
ADBT8-Kneutral3/10Advasa Holdings announced a dividend policy targeting a 50% annual payout ratio on net income, beginning fiscal year endOct 16, 2026
IONQ8-Kbearish7/10IonQ priced a public offering of 20.5M common shares, 29.5M pre-funded warrants (exercise price $0.0001), and 100M SerieOct 16, 2026
ACAA8-Kneutral2/10Mary Szela resigned from the board of directors and its audit and compensation committees effective October 16, 2026, wiOct 16, 2026
HURA8-Kneutral2/10TuHURA Biosciences drew an additional $650,000 under its existing $50 million revolving credit facility with Parkview HoOct 16, 2026
PMCB8-Kbearish5/10PharmaCyte Biotech dismissed its auditor, CBIZ CPAs, and engaged Grassi & Co. as its new independent registered public aOct 16, 2026
WSBF8-Kneutral2/10Director Derek L. Tyus resigned from the boards of Waterstone Financial and WaterStone Bank effective October 20, 2026, Oct 16, 2026
MDCX8-Kneutral3/10Medicus Pharma Ltd. filed an 8-K reporting a 1-for-50 reverse stock split (share consolidation) effective October 12, 20Oct 16, 2026
LYV8-Kbullish6/10Live Nation closed a $730M USD + €600M senior notes offering (7.125% / 6.125% due 2032) and amended its credit facilitieOct 16, 2026
LASE8-Kneutral4/10Laser Photonics Corp announced the appointment of founder Dmitri Nikitin as Executive Chairman and principal executive oOct 16, 2026
COST8-Kneutral2/10Costco filed an 8-K disclosing the Compensation Committee's approval of the Fiscal 2027 Executive Bonus Plan. The plan sOct 16, 2026
ETN8-Kneutral2/10Eaton filed this 8-K solely to recast segment financial information from its 2025 Form 10-K, reflecting the creation of Oct 16, 2026
KINS8-Kneutral2/10Kingstone Companies announced it will report Q3 2026 earnings on November 5, 2026, with a conference call the following Oct 16, 2026
ALEC8-Kbearish7/10Alector priced a dilutive underwritten offering of 36.6M shares at $2.05/share, raising ~$75M in gross proceeds. The offOct 16, 2026
CALC8-Kbearish5/10CFO Stephen Bardin resigned effective after the Q3 2026 10-Q filing to pursue another opportunity, with no disagreement Oct 16, 2026
TCRX8-Kneutral2/10Two board members, Garry Nicholson and Gabriela Gruia, M.D., resigned from TScan Therapeutics' board effective October 1Oct 16, 2026
« Previous Page 83 of 334 Next »